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Abstract
Background: Hypoxia-inducible factor 1 (HIF-1a) expression induced by hypoxia plays a critical role in promoting tumor
angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1a in tumor cells remain
unknown.
Methodology/Principal Findings: In this study, we reported that hypoxia could induce HIF-1a and VEGF expression
accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an
inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1a and VEGF expression.
Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126
suppressed hypoxia-induced Rac1 activation as well as HIF-1a expression. Moreover, hypoxia treatment resulted in a
remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced
ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1a expression.
Conclusions/Significance: Taken together, our study demonstrated that hypoxia-induced HIF-1a expression involves a
cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of
Rac1.
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Introduction
Angiogenesis is a relatively early event in the progression of
human cancer. Increased tumor angiogenesis correlates closely
with tumor growth, hematogenous metastasis and poor cancer
prognosis [1,2]. It has been proposed that a wide variety of
cytokines secreted by tumor cells such as vascular endothelial
growth factor (VEGF) [3], basic fibroblast growth factor (bFGF),
platelet-derived growth factor (PDGF) [4], erythropoietin [5], and
insulin-like growth factor (IGF) [6] may stimulate angiogenesis.
Hypoxia, a characteristic feature of many human malignancies
[7,8], can stimulate the expression of numerous angiogenic factors by
the induction of hypoxia-inducible factor-1 (HIF-1), which is a
heterodimeric protein composed of HIF-1a and HIF-1b subunits.
HIF-1b is known as the aryl hydrocarbon receptor nuclear
translocater and is constitutively expressed in cells.HIF-1aexpression
is precisely regulated by cellular O2 concentration. Under normoxia,
HIF-1a is found to bind to von Hippel-Lindau protein (pVHL), then
ubiquitinated and degraded through the proteasomal pathway.
However, hypoxia inhibits HIF-1a hydroxylation and allows its
translocation to the nucleus, where it binds to HIF-1b to form an
active complex and initiates the transcription of VEGF and other
angiogenic factors [9,10,11]. Although the role of HIF-1a in
angiogenesis has been reported, the upstream signaling events
stimulating HIF-1a expression activated by hypoxia are still not well
characterized.
Rac1 is one of the best-characterized member of small GTPases
[12]. Intracellularly, the GTP-bound form of Rac1interacts with
downstream effectors that control multiple cellular processes,
including cytoskeleton organization [13], membrane trafficking
[14], and gene transcription [15]. A growing body of evidence
indicates that Rac1 can be activated by stress stimuli such as
hypoxia [16]. The activation of Rac1 in hepatocellular carcinoma
is correlated with VEGF expression and metastasis in vivo [17].
Impairment of ischemia-induced angiogenesis is also reported in
Rac1 haploinsufficient mice [18]. Rac1 regulates the active
NADPH oxidase complex assembly in most cells, and is
recognized as a critical determinant of intracellular redox status
[19]. Recent studies have shown that Rac1 is involved in the
control of angiogenesis by inducing ROS production [20,21]. In
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[22,23] and extracellular signal-regulated kinase (ERK) [24,25]
has been identified as potent modulators of HIF-1a expression.
ERK has also been identified as a potent modulator of Rac1 in
different cancer cell types [26,27]. In addition, a recent study
showed that hypoxia-induced IL-18 increases Rac1 activity and
HIF-1a expression in a PI3K/Akt-dependent manner [28]. Thus,
it is worthwhile to explore whether PI3K and ERK signaling
pathways are involved in hypoxia-induced Rac1 activation and
HIF-1a induction in breast cancer cells. The results in the present
study indicate that PI3K and ERK-mediated activation of Rac1 is
involved in hypoxia-induced expression of HIF-1a, and hypoxia-
induced ROS production initiates such signaling activation and
HIF-1a expression.
Results
Hypoxia upregulates HIF-1a expression and activity in
vitro
It is widely accepted that HIF, and more specifically HIF-1a,i s
a central regulator of the cellular pathways under hypoxia [9]. To
assess the effect of hypoxia on HIF-1a expression in breast cancer
cells, MCF-7 cells were cultured under hypoxia for the indicated
times. The results in Fig. 1A showed by immunoblotting assays
that hypoxia induced an approximately 2-fold increase in HIF-1a
levels in MCF-7 cells within 1 h. HIF-1a levels peaked at 2 h of
hypoxia, and returned to the basal level at 4 h. We wished to
further examine whether there were similar changes in HIF-1a
expression at the transcriptional levels in MCF-7 cells. Our RT-
PCR assays demonstrated that, indeed, the mRNA transcript
levels of HIF-1a significantly increased in these cells in response to
hypoxia, rapidly reaching the peak at 1 h and thereafter tapering
off within 4 h (Fig. 1B). To determine whether this increase in
HIF-1a expression was associated with an upregulation of HIF-1a
transcriptional activity, we next analyzed the expression of the
VEGF gene, a frequently used HIF-1a target gene [29]. We found
that the VEGF mRNA transcript levels were significantly
increased in MCF-7 cells under hypoxia (Fig. 1B).
Hypoxia stimulates HIF-1a expression through activating
Rac1
Accumulating evidence has indicated that Rac1 can be activated
byvariousstressstimulisuchashypoxia[16].Wewished toexamine
whether Rac1 influences HIF-1a expression in breast cancer cells
under hypoxia. We first investigated whether hypoxia could
regulate Rac1 expression and activation. Our pulldown assays
revealed that hypoxia induced Rac1 activation withan early peak at
1 h, which then returned to the basal levels while the level of Rac1
in MCF-7 cells remained unmodified during 4 h of hypoxia
(Fig. 2A). To determine whether hypoxia-induced HIF-1a expres-
sion is Rac1-dependent, we blocked Rac1 activity by transfecting
these cells with Rac1 T17N, and examined HIF-1a expression
during hypoxia. We found that, in cells transfected with the empty
vector, HIF-1a expression was increased approximately 2 folds
under hypoxia compared with their counterparts grown under
normoxia. However, Rac1 T17N significantly attenuated hypoxia-
induced increase in HIF-1a expression (Fig. 2B).
We further examined whether Rac1 regulated HIF-1a and
VEGF at the transcriptional level. Our RT-PCR assays indicated
that Rac1 T17N did not have any effect on the mRNA expression
of HIF-1a, However, Rac1 T17N significantly attenuated
hypoxia-induced increase in VEGF mRNA transcript levels
(Fig. 2C). Additionally, we examined the effect of Rac1 on
hypoxia-induced HIF-1a expressions by knocking down Rac1
expression with appropriate siRNAs in MCF-7 cells. We found
that, compared with scrambled siRNA (mock), siRNA against
Rac1 effectively reduced Rac1 expression in MCF-7 cells under
normoxia (Fig. 2D). Under hypoxic conditions, siRNA against
Rac1 noticeably attenuated hypoxia-induced increase in the
protein levels of HIF-1a (Fig. 2E). We further examined whether
Rac1 could activate HIF-1a. We transfected MCF-7 cells with
either empty vectors or vectors encoding the active mutant of
Rac1 Q61L. Our immunoblotting assays demonstrated that the
active mutant of Rac1 Q61L markedly increased the protein levels
of HIF-1a under normoxia (Fig. 2F). These results showed that,
under hypoxia, Rac1 can regulate HIF-1a expression and in turn
its transcriptional activities in vitro.
Figure 1. Hypoxia induces HIF-1a and VEGF expression in breast cancer cells. Confluent, serum-starved cells were incubated under
normoxia or hypoxia for the indicated periods. (A) Total cellular proteins were extracted and analyzed for HIF-1a expression in MCF-7 cells by
immunoblotting assays. A representative immunoblot of 5 independent experiments is shown here (upper panel). Protein densitometry was
performed with the level of HIF-1a normalized against GADPH (lower panel). (B) Total cellular RNAs were extracted and analyzed for HIF-1a and VEGF
mRNA expressions in MCF-7 cells as described under ‘Materials and Methods’. Data are presented as mean6SD of 5 independent determinations.
*: P,0.05, referring to the difference between cells under hypoxia and those under normoxia.
doi:10.1371/journal.pone.0025213.g001
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nuclear translocation of HIF-1a in MCF-7 cells
To further determine whether hypoxia stimulates HIF-1a
expression in a Rac1-dependent manner, we examined HIF-1a
expression in MCF-7 cells under hypoxia by immunofluorescence
microscopy. We found that HIF-1a showed weak expression and
was localized in the cytoplasm of serum-starved MCF-7 cells under
normoxia.At2 hafterexposuretohypoxia,HIF-1aabundancewas
obviously increased in both the cytoplasm and nucleus of these cells.
However, Rac1 T17N noticeably attenuated theincrease inHIF-1a
expression and the subsequent nuclear translocation (Fig. 3).
PI3K and ERK signaling mediate hypoxia-induced Rac1
activation and HIF-1a expression
Previous report has shown that both PI3K and ERK can
activate HIF-1a in laser-induced rat choroidal neovascularization
[30]. It is possible that these proteins affect HIF-1a expression in
hypoxic breast cancer cells. We first quantified the levels of
activated PI3K and ERK in normoxic or hypoxic MCF-7 cells by
immunoblotting analysis of phospho-Akt (Ser473), a well-accepted
downstream target of PI3K, and phospho-ERK [31,32]. We found
that the levels of both phospho-Akt and phospho-ERK were
significantly increased at 1 h after hypoxia, whereas the total
protein amounts of Akt and ERK remained unaltered (Fig. 4A).
To determine whether the PI3K and ERK signaling pathway is
involved in hypoxia-induced Rac1 activation, we blocked PI3K
activity by using LY294002 (PI3K inhibitor) or U0126 (MEK/
ERK inhibitor) and examined Rac1 activity after hypoxia. The
results showed that pretreatment with 10 mM LY294002 largely
inhibited hypoxia-induced Rac1 activity (Fig. 4B). Rac1 activity
was also partially inhibited by 10 mM U0126 (Fig. 4B). These
results suggest that PI3K and ERK act as the upstream effector of
Rac1 activation. We further investigated the effects of PI3K and
ERK inhibitors on HIF-1a protein and mRNA expressions in
MCF-7 cells. As expected, HIF-1a protein levels increased
approximately 2-folds in hypoxic cells compared with those in
normoxic cells. Pretreatment with 10 mM LY294002 or 10 mM
U0126 largely abolished the stimulatory effect of hypoxia on
Figure 2. Rac1 activation is required for hypoxia-induced HIF-1a and VEGF expression. (A) Effect of hypoxia on Rac1 activation. Serum-
starved MCF-7 cells were incubated under normoxia or hypoxia for the indicated periods. Cellular lysates were assayed for active Rac1 by pulldown
assays as described in ‘Materials and methods’. Data are presented as mean 6 SD of 5 independent determinations. (B&C) Overexpression of Rac1-
T17N in cells inhibited hypoxia-mediated HIF-1a and VEGF expression. Cells transfected with empty vector or Rac1-T17N were grown under hypoxia
for 2 h, HIF-1a protein (B), HIF-1a and VEGF mRNA expressions (C) were examined by immunoblotting or RT-PCR assays. (D) The effect of siRNA on
the intracellular levels of Rac1. Total protein extracts from MCF-7 cells transfected with siRNA-Rac1 or scrambled siRNA (mock) were analyzed by
Western blotting for Rac1. GAPDH was used a loading control. (E) Rac1 silencing inhibits HIF-1a expression. Cells transfected with empty vector or
60 nmol/L Rac1 siRNA were grown under hypoxia for 2 h, and HIF-1a protein were examined by immunoblotting assays. (F) Overexpression of Rac1-
Q61L promoted HIF-1a expression. Cells were transfected with empty vector or Rac1-Q61L and HIF-1a expression was examined. *: P,0.05, referring
to the difference between cells treated with and those without hypoxia.
#: P,0.05 (t-test), referring to the difference between the cells transfected
with Rac1 siRNA or Rac1-T17N or Rac1-Q61L and the cells transfected with scrambled siRNA (mock) or empty vector.
doi:10.1371/journal.pone.0025213.g002
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inhibited by LY294002, and PI3K activity was not inhibited by
U0126 (Fig. 4C and 4D). Furthermore, LY294002 or U0126
attenuated the level of activated VEGF mRNA transcripts, but did
not change the activated HIF-1a mRNA transcription level under
hypoxia (Fig. 4E), demonstrating that ERK and PI3K did not
regulate HIF-1a expression during hypoxia at the transcriptional
level.
ROS generation is required for hypoxia-induced
activation of PI3K, ERK, and Rac1 and HIF-1a expression
It has been well documented that one of the main mediators of
hypoxia in cells is ROS production [33,34], and recent work has
shown that ROS could regulate ovarian tumor angiogenesis and
growth [35]. We examined the effect of hypoxia on ROS
generation in cultured breast cancer cells by fluorescent staining
with CM2-DCFHDA to measure endogenous H2O2 levels. The
staining results revealed that H2O2 abundance was weak in serum-
starved cultured cells, but increased dramatically under hypoxia.
The role of ROS generation in hypoxia was further investigated by
treatment of cells with N-acetyl-L-cysteine (NAC), a known
scavenger of ROS. Two mM NAC prior to hypoxia diminished
the production of H2O2 induced by hypoxia (Fig. 5A) with a
corresponding reduction in hypoxia-induced PI3K, ERK and
Rac1 activation. Furthermore, basal and hypoxia-stimulated HIF-
1a expression was blocked markedly by pretreatment with NAC,
while HIF-1a mRNA levels remained unchanged (Fig. 5B–D). To
determine whether hypoxia stimulated ROS production was
depended on NADPH oxidase activation, we treated cells with
NADPH oxidase inhibitor diphenylene iodonium (DPI) before
hypoxia. However, we found that the production of H2O2 by
hypoxia was not altered in the presence of DPI (Figure S1). We
also investigated whether ROS is involved in hypoxia-induced
HIF-1a expression by immunofluorescence staining. As shown in
Fig. 6, the inhibition of ROS by NAC before hypoxia prevented
an increase in fluorescence intensity of HIF-1a protein in MCF-7
cells. Furthermore, we found that HIF-1a expression by hypoxia
was inhibited by LY294002 or U0126. These results indicate that
hypoxia can stimulate ROS generation in breast cancer cells,
which acts as the upstream effector of PI3K and ERK in
mediating Rac1 activation and HIF-1a expression in hypoxic
MCF-7 cells.
Discussion
HIF-1a is involved in tumor angiogenesis and metastasis by
regulating genes involved in response to hypoxia. Clinical evidence
showed that HIF-1a is associated with a worse prognosis in
patients with invasive breast carcinoma [36]. In the present study,
HIF-1a mRNA and protein expression was increased breast
cancer cells undergoing hypoxia. The mRNA transcript levels of
HIF-1a target gene VEGF were also upregulated by hypoxia.
Therefore, hypoxia directly induces the expression and activation
of HIF-1a in breast cancer cells, which is a critical step in tumor
angiogenesis.
A primary observation in the present study is that hypoxia
induced Rac1 activation in a time-dependent fashion in breast
cancer cells. We further observed that hypoxia not only enhanced
the protein level of HIF-1a in the cytoplasm and but also increased
its redistribution from the cytoplasm to the nucleus. Rac1 is a
known effector for pVHL suppression and linked to HIF-1a
stabilization in hypoxia [37]. Rac1 activation promotes angiogen-
esis of various types of vascular endothelial cells [20,38], and
mediates hypoxia-stimulated breast cancer cell migration [39,40].
A previous study has demonstrated that Rac1 activity corresponds
with angiogenesis in hepatocellular carcinoma [17]. Similarly, our
results showed that Rac1 Q61L increased HIF-1a protein
expression in MCF-7 cells while preventing Rac1 activity by
Rac1 T17N and siRNA Rac1 increased the HIF-1a protein and
VEGF mRNA reduction under hypoxia, suggesting that hypoxia-
induced Rac1 activity was responsible for the expression and
activation of HIF-1a in breast cancer cells. Interestingly, we failed
to observe any changes in HIF-1a mRNA transcript levels for
Rac1 transfectants, indicating that Rac-induced HIF-1a expres-
sion in breast cancer cells is independent of mRNA regulation.
We next examined the potential activators for Rac1 in our
system. PI3K and ERK are two major signaling pathways in
regulating in vivo and in vitro angiogenesis [41,42]. A previous study
has demonstrated that PI3K and ERK signaling pathway induces
the VEGF expression as well as promotes an increase in the
development of choroidal neovascularization [30]. Shi YH. et al.
also reported that bFGF induces HIF-1a activation and VEGF
release in T47D breast cancer cell line involves PI3K/Akt and
MEK1/ERK pathways [43]. Similar to these findings, our results
revealed that hypoxia elevated not only the level of PI3K activity
but also ERK phosphorylation in breast cancer cells. Furthermore,
specific chemical inhibitors for these proteins cause the reduction
of hypoxia-induced Rac1 activity and HIF-1a protein expressions.
Therefore, it may be reasonable to speculate think that hypoxia-
induced activation of Rac1 activation and enhanced HIF-1a
protein stabilization is mediated through PI3K and ERK
pathways. Although it is reported that ERK and PI3K could
have crosstalk in some conditions [44], it is likely that hypoxia may
act on two parallel and distinct signalling pathways to induce Rac1
activity, because ERK phosphorylation was not inhibited by PI3K
inhibitor, and PI3K activity was not inhibited by ERK inhibitor
either.
It remains unclear how PI3K causes the activation of Rac1
upon hypoxia. Akt is a crucial downstream effector of PI3K and is
likely to be responsible for many biological consequences of PI3K
Figure 3. Rac1 activation is required for hypoxia-stimulated
nuclear translocation of HIF-1a in MCF-7 cells. Cells transfected
with GFP-Rac1-T17N or GFP (green) were grown under hypoxia for 2 h
a n de x a m i n e dH I F - 1 a expression (red) by immunofluorescence
microscopy as described in ‘Materials and methods’. The cells were
counter-stained with DAPI (blue). Images are representative of at least 3
independent determinations. The illustrations in the right side column
show the merged images of HIF-1a and GFP fluorescence. Arrows in the
left-bottom panel point to HIF-1a expression in cells transfected with or
without GFP-Rac1-T17N. Cells transfected with GFP-Rac1-T17N showed
weak HIF-1a (red) immunofluorescence staining compared with cells
without transfection under hypoxia. Magnification, 6400.
doi:10.1371/journal.pone.0025213.g003
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activation of GSK-3b, p70S6K1 and mTOR, and all of them were
able to activate Rac1 [45,46,47,48], suggesting that hypoxia
stimulates Rac1 activation in breast cancer cells by activating
PI3K/Akt signaling. It is not clear whether PI3K and ERK
mediates HIF-1a protein expression through other ways in our
Figure 4. Hypoxia activates Rac1 via the PI3K and ERK pathway that is required for hypoxia-induced HIF-1a expression. (A) Effect of
hypoxia on the activation of PI3K and ERK. Serum-starved MCF-7 cells were grown under normoxia or hypoxia for the indicated periods. Hypoxia-
stimulated phosphorylation of Akt at Ser 473 and phosphorylation of ERK at Thr202/Tyr204 was determined as described in ‘Materials and methods’.
(B) Hypoxia induced activation of Rac1 was dependent on PI3K and ERK. After treatment with 10 mM LY294002 or 10 mM U0126 for 1 h, the cells were
incubated under hypoxia for 1 h and Rac1 activity was examined. (C) Hypoxia induced HIF-1a expression was dependent on PI3K. (D) Hypoxia
induced HIF-1a expression was dependent on ERK. After treatment with 10 mM LY294002 (C) or 10 mM U0126 (D) for 1 h, MCF-7 cells were incubated
under hypoxia for 1 h and were analyzed by PI3K, ERK or HIF-1a assays as described in ‘Materials and methods’. (E) Effects of LY294002 or U0126 on
HIF-1a and VEGF mRNA expression in hypoxic cells. After pretreatment with 10 mM LY294002 or 10 mM U0126 for 1 h, the cells were incubated under
hypoxia for 1 h and HIF-1a mRNA expressions was examined. Data are presented as mean 6 SD of 5 independent determinations. *: P,0.05, referring
to the difference between cells treated with and those without hypoxia.
#: P,0.05 (t-test), refers to the comparison of cells treated with hypoxia plus
LY294002 or U0126 and the cells treated with hypoxia alone.
doi:10.1371/journal.pone.0025213.g004
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to the nucleus, where ERK may exert part of its biological activity
[49]. Previous report suggested that phosphorylation of p300 by
the ERK increases HIF-1a transcriptional activity by increasing
HIF-1/p300 complex formation [50]. However, our results
showed that decreased activation of PI3K or ERK by inhibitor
did not change the activated HIF-1a mRNA transcription level
under hypoxia in MCF-7 human breast cancer cells. The role of
other signaling molecules that function downstream of PI3K and
ERK in controlling HIF-1a expression remains to be determined.
ROS plays a central role in the key intracellular signal
transduction pathway for regulation of angiogenesis [51,52]. An
earlier report showed that thymosin beta-4-induced HIF-1a
stabilization in human cervical tumor cells is ROS-dependent
[53]. However, the mechanism whereby ROS influences HIF-1a
expression has not been described. Some studies reported that
overproduction of ROS induced HIF-1a accumulation via the
PI3K/Akt-PKC-HDAC pathway [54]. In contrast, our results
show that hypoxia increased the production of ROS in breast
cancer cell line MCF-7. Furthermore, decreased activation of
PI3K and Rac1 and reduced phosphorylation of ERK were
observed after inhibition of ROS production, which correlated
with ablation of HIF-1a expression, thus suggesting a dependency
of ROS on the PI3K/Akt and ERK signaling pathways, as well as
Rac1 activation and HIF-1a expression in MCF-7 cells.
It is noteworthy that Rac1 constitutes part of the structure of
NADPH oxidase whereby it participates in the control of the
intracellular ROS machinery [55]. However, in our study,
decreased ROS production by NAC, a known scavenger of
ROS, reduced Rac1 activation and HIF-1a expression. On the
other hand, ROS production was not altered after abolition of
NADPH oxidase activity by DPI (Figure S1). This result is
consistent with findings showing that NAC inhibited Rac1 activity
in response to LPS in macrophages [56]. Therefore, it may be
reasonable that hypoxia-stimulated ROS generation in breast
cancer cell line MCF-7 is independent of Rac1 activation.
ROS is supposed to act as an inhibitor of prolyl-4-hydroxylase
(PHD), which mediates HIF-1a ubiquitination and degradation by
hydroxylation of two specific proline residues of HIF-1a [57].
Therefore, it is not clear whether ROS induces HIF-1a expression
Figure 5. ROS generation is required for hypoxia-induced activation of PI3K, ERK and Rac1 and HIF-1a expression. (A) Representative
micrographs of MCF-7 cells growing under normoxia or hypoxia without or with 2 mM NAC and stained with CM2-DCFHDA. (B) Effect of NAC on HIF-
1a and VEGF mRNA expressions in hypoxic cells. After pretreatment with 2 mM NAC for 1 h, the cells were incubated under hypoxia for 1 h and HIF-
1a and VEGF mRNA expressions was examined. (C&D) Effect of ROS inhibitor on hypoxia-stimulated PI3K, ERK and Rac1 activation and HIF-1a
expression. After preincubation for 1 h with 2 mM NAC, cells were grown under hypoxia for 1 h and then cells were analyzed by Akt or ERK or Rac1 or
HIF-1a assay as described in ‘Materials and methods’. Data are presented as mean 6 SD of 5 independent determinations. *: P,0.05, referring to the
difference between cells treated with and those without hypoxia.
#: P,0.05 (t-test), refers to the comparison of cells treated with hypoxia plus NAC
and the cells treated with hypoxia alone.
doi:10.1371/journal.pone.0025213.g005
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PI3K or ERK activation in breast cancer cells in this study
remains to be elucidated. Papaiahgari et al. suggested that
epithelial growth factor receptor (EGFR) is the upstream regulator
of both PI3K/Akt and MEK/ERK signaling pathways [58]. In
accordance with previous studies, ROS notably induced EGFR
activation in some cell types [58,59], and we assume that ROS
leading to EGFR activation possibly is related to PI3K and ERK
activation during hypoxia. The mechanism whereby hypoxia
regulates PI3K and ERK activation remains to be elucidated.
In summary, this study highlighted the role of Rac1 in the
regulation of HIF-1a expression in hypoxic MCF-7 human breast
cancer cells. PI3K and ERK-mediated activation of Rac1 is
involved in hypoxia-induced production of HIF-1a. We have also
found that hypoxia can stimulate ROS generation in breast cancer
cells, which may serve as an important mediator for hypoxia to
stimulate Rac1 activation through the activation of PI3K and
ERK signaling pathway. The function and regulation of HIF-1a
expression may be of major clinical importance and may provide
new insights for the discovery of novel therapeutic targets.
Materials and Methods
Cells and plasmids
Human breast cancer cell line MCF-7 was obtained from the
American Type Culture Collection (ATCC, Manassas, VA) and
maintained at 37uC in high glucose Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco,Grand Island, NY) supplemented with
10% (v/v) fetal bovine serum (FBS) (Hyclone, Logan, UT), 100
units penicillin/ml, and 100 mg/ml streptomycin in a humidified
atmosphere. For growth under hypoxia, the cells were incubated
at 37uC in a modular chamber flushed with 1% O2,5 %C O 2 and
94% N2. Cells were grown on coverslips for fluorescence staining
and on plastic dishes for protein and mRNA extraction. Cells were
made quiescent by serum starvation overnight followed by
treatment. For drug studies, 10 mM LY294002 (Sigma, St. Louis,
MO) or 10 mM U0126 (Alexis, Lausen, Switzerland) or 2 mM
NAC (Sigma, St. Louis, MO) was added to the medium for 1 h
before hypoxia.
pEGFP-C2 vector containing dominant negative Rac1-T17N
insert or dominant positive Rac1-Q61L was kindly provided by
Dr. Shoshana Ravid (The Hebrew University, Jerusalem, Israel).
MCF-7 cells were transfected with either pEGFP-C2 or pEGFP-
C2 expressing Rac1-T17N using Lipofectamine 2000 as instructed
by the manufacturer (Invitrogen, Carlsbad, CA). The sequence of
small interfering RNA (siRNA) for Rac1 was 59-GUUCUUA-
AUUUGCUUUUCCTT-39 and for the scrambled sequence
59-GUACCGCACGUCAUUCGUAUC-39 (GenePharma Co.,
Shanghai, China). Cells were grown until approximately 60%
confluent and then transfected with Rac1 siRNA or scrambled
siRNA using Lipofectamine 2000 as instructed by the manufacturer.
Western blotting and immunofluorescence studies
Cellular lysates and immunoblotting were performed as
previously depicted [60]. The following antibodies were used:
rabbit anti-Akt antibody, rabbit anti-phospho-Akt (Ser473)
antibody, rabbit anti-HIF-1a antibody (Cell Signaling Technolo-
gy, Beverly, MA), rabbit anti-ERK antibody and anti-phospho-
ERK (Thr202/Tyr204) antibody (Santa Cruz Biotechnology,
Santa Cruz, CA), and mouse anti-GAPDH antibody (Chemicon,
Temecula, CA). Digital images of the immunoblotts were obtained
with a Chemidoc XRS and analyzed using the image analysis
program Quantity One (Bio-Rad, Hercules, CA). For immuno-
fluorescence studies, cells were fixed in 3.7% paraformaldehyde in
phosphate buffered saline (PBS) for 30 min, permeabilized in
0.1% Triton X-100 and blocked in PBS containing 1% bovine
serum albumin (BSA) for 1 h at room temperature. The cells were
incubated with rabbit anti-HIF-1a antibody (Novus, Littleton,
Colorado) for 2 h followed by incubation with rhodamine
conjugated anti-rabbit antibody for 1 h at room temperature
within a moist chamber. Following wash with PBS, the cover slips
were mounted on glass slides with DAPI Fluoromount G
(Southern Biotech, Birmingham, AL). Images were collected using
an Olympus BX51 microscope coupled with an Olympus DP70
digital camera.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNAs were isolated with the TRIzol reagent according to
the manufacturer’s protocol (Invitrogen, Carlsbad, CA). Then,
cDNA was synthesized using the SuperScript First Strand
Synthesis System (Invitrogen) and amplified by polymerase chain
reaction (PCR) using the following primers: GAPDH: 59-
TGAACGGGAAGCTCACTGG-39 (sense) and 59-TCCACCA-
CCCTGTTGCTGT A-39 (antisense); HIF-1a:5 9-ACAAGTC-
ACCACAGGACA-39 (sense) and 59-AGGGAGAAAATCAAG-
TCG-39 (antisense); VEGF: 59-CGGGAACCAGAT CTCTCA-
CC-39 (sense) and 59-AAAATGGCGAATCCAATTCC-39 (anti-
sense). The PCR for GAPDH was performed in 26 cycles at 95uC
for 30 s, 58uC for 30 s, and 72uC for 30 s, for HIF-1a in 28 cycles
at 95uC for 30 s, 46.6uC for 30 s, and 72uC for 40 s, and for
VEGF in 28 cycles at 95uC for 30 s, 56uC for 30 s, and 72uC for
Figure 6. ROS inhibition reverses hypoxia-stimulated HIF-1a
accumulation and nuclear translocation in MCF-7 cells. After
pretreatment with 2 mM NAC, 10 mM LY294002 or 10 mM U0126 for
1 h, cells were grown under hypoxia for 2 h and stained for HIF-1a (red)
as described in ‘Materials and methods’. Cells were counterstained with
DAPI (blue). Images are representative of at least 3 independent
determinations. The illustrations in the right side column show the
merged images of HIF-1a and DAPI. Magnification, 6400.
doi:10.1371/journal.pone.0025213.g006
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agarose. Images of electrophoresis were taken using the Chemi-
DOC XRS Imaging system (Bio-Rad, Hercules, CA).
Pulldown assays
Rac1 activity was measured as previously depicted [61]. In
brief, equal volumes of total cellular protein were incubated with
GST-RBD (a gift from James E Casanova, University of Virginia,
VA) beads captured on MagneGST Glutathione Particles
(Promega, Madison, WI) for 1 h at 4uC. The particles were then
washed three times with washing buffer containing 4.2 mM
Na2HPO4, 2 mM KH2PO4, 280 mM NaCl, and 10 mM KCl
(pH 7.2), resuspended in 26SDS sample buffer and subjected to
immunoblotting analysis by using a mouse anti-Rac1 antibody
(Upstate Biotechnology, Lake Placid, NY).
Intracellular ROS staining
For intracellular ROS staining, 1610
5 MCF-7 cells were seeded
on a coverslip placed in a 6-well plate and incubated overnight.
After cells were treated with appropriate inhibitors and stimuli as
detailed elsewhere in the text, they were stained with 5 mM2 9,79-
dichlorofluorescein diacetate (CM2-DCFHDA) (Invitrogen) for
15 min at 37uC, washed with PBS three times, and fixed with 4%
formaldehyde. After wash with PBS, the cover slips were mounted
on glass slides with Fluoromount (Sigma). Images were collected
using an Olympus BX51 microscope coupled with an Olympus
DP70 digital camera.
Statistical analysis
Statistical analysis was carried out using the SPSS software.
Student’s t test was used to analyze the differences between two
groups. When comparisons between multiple groups were carried
out, one-way ANOVA followed by SNK tests were employed.
Statistical significance was considered at P,0.05.
Supporting Information
Figure S1 Effect of DPI on hypoxia-stimulated ROS
production. After pretreatment with 10 mM DPI for 1 h, cells
were grown under hypoxia for 1 h and stained with CM2-
DCFHDA. Images are representative of at least 3 independent
determinations. Magnification, 6400.
(TIF)
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